• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SYNH

SYNH

Syneos Health, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD42.98

+0.01 (+0.02%)

Company Profile

CEO

Michelle Keefe

IPO Date

2014-11-07

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$42.98

Prev. Close

$42.97

Day Low

$42.97

Day High

$42.99

52W Low

$22.89

52W High

$52.23

Market Cap

$4.46B

Volume

6.70M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

46.0%

Avg Negative

2.8%

Avg Neutral

51.3%

News Feed

Syneos Health Schedules Second Quarter 2021 Earnings Call for Monday, August 9, 2021

GlobeNewsWire·7/12/2021·↓ negative

Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with Site Sponsors

GlobeNewsWire·6/21/2021·↑ positive

Syneos' (SYNH) New Patient Consortium to Drive Innovation

Zacks Investment Research·6/8/2021
·↑ positive

Syneos Health Launches Patient Voice Consortium

GlobeNewsWire·6/3/2021·↑ positive

Syneos Health: Up 25%, But There's Room For Additional Growth

Seeking Alpha·5/7/2021·↑ positive

Syneos Health, Inc. (SYNH) CEO Alistair Macdonald on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/2/2021·↓ negative

Syneos Health (SYNH) Q1 Earnings Top Estimates, Margins Up

Zacks Investment Research·4/30/2021·↑ positive

Illingworth Research Group Recognized with Queen's Award for Enterprise: International Trade 2021

GlobeNewsWire·4/30/2021·↑ positive

Syneos Health (SYNH) Tops Q1 Earnings and Revenue Estimates

Zacks Investment Research·4/29/2021·↑ positive

Recap: Syneos Health Q1 Earnings

Benzinga·4/29/2021·↑ positive